Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_assertion type Assertion NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_head.
- NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_assertion wasGeneratedBy ECO_0000203 NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_provenance.
- NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_assertion wasDerivedFrom befree-20140225 NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_provenance.
- NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_assertion SIO_000772 10481934 NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_provenance.
- NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_assertion evidence source_evidence_literature NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_provenance.
- NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_assertion description "[These results suggest that MCT, as opposed to LCT, is useful for treatment of type I hyperlipidemia with a novel mutation at the notable amino acid Asn 291 of the LPL gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580540.RAWrQtsQBTxFGe0vTpvJRf9jabD8h2Gee_8yRgcImHxQw130_provenance.